Predictors of adverse outcomes in acute pancreatitis: new horizons

Area of Science:

• Gastroenterology and Hepatology
• Critical Care Medicine

Background:

• Acute pancreatitis (AP) presents a significant clinical challenge with high mortality rates, particularly when associated with organ failure or infected necrosis.
• Accurate prediction of adverse outcomes in AP is essential for timely intervention and improved patient management.
• Current predictive tools for AP lack ideal accuracy, necessitating further research into reliable biomarkers.

Purpose of the Study:

• To evaluate the efficacy of various single- and multi-parameter predictors for identifying patients with adverse outcomes in acute pancreatitis.
• To identify feasible and accurate predictors for AP management, especially within the Indian healthcare context.

Main Methods:

• Review and analysis of existing single- and multi-parameter predictors for acute pancreatitis.
• Assessment of the clinical utility and feasibility of identified predictors in predicting adverse outcomes.

Main Results:

• Blood urea nitrogen and the harmless acute pancreatitis score demonstrate utility and feasibility for AP management in India.
• Other single-parameter predictors (serum creatinine, hematocrit, ESR, CRP, D-dimer) require further validation in large-scale prospective studies.
• Multi-parameter tools like the Bedside Index of Severity of Acute Pancreatitis (BISAP) may have limited applicability in routine clinical practice.

Conclusions:

• Blood urea nitrogen and the harmless acute pancreatitis score are promising predictors for adverse outcomes in acute pancreatitis, particularly in Indian settings.
• Further high-quality, large-scale prospective studies are needed to validate other potential biomarkers.
• Simpler, feasible predictors are preferred for daily clinical use in managing acute pancreatitis.